✦ LIBER ✦

Primary tacrolimus immunosuppression in kidney recipients considered “higher immunological risk”

✍ Scribed by F Braun; T Lorf; E Schütz; R Canelo; U Hanack; K Döpkens; B Sattler; C Grupp; B Ringe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary tacrolimus immunosuppression in

✍ F Braun; T Lorf; E Schütz; R Canelo; U Hanack; K Döpkens; B Sattler; C Grupp; B 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Pharmacokinetics of tacrolimus primary i

✍ F Braun; E Schütz; B Peters; R Talaulicar; C Grupp; N Undre; A Schäfer; V.W Arms 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Primary Low-Dose Tacrolimus Immunosuppre

✍ F Braun; T Lorf; C Grupp; E Schütz; B Sattler; R Canelo; G.A Müller; B Ringe 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Use of Basiliximab Induction in Low–Immu

✍ E. Gavela Martı́nez; A.I. Ávila Bernabeu; A. Sancho Calabuig; S. Beltrán Catalán 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 93 KB

A prospective 3-yr evaluation of tacroli

✍ Jeffrey S. Zaltzman; Anne Boucher; Stephan Busque; Phillip F. Halloran; David N. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Basiliximab Does Not Reduce the Early Re

✍ W.H. Cho; H.J. Lee; H.T. Kim; E.A. Hwang; S.Y. Han; S.B. Park; H.C. Kim 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 88 KB